IMM60 and Pembrolizumab in Melanoma and NSCLC
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Pilot Study to Determine Pro-Inflammatory Cytokine Kinetics During Immune Checkpoint Inhibitor Therapy
- Status
- COMPLETED
- Phase
- N/A
Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine
- Status
- COMPLETED
- Phase
- N/A
Spanish Academy of Dermatology and Venereology (AEDV) Melanoma Registry
- Status
- RECRUITING
- Phase
- N/A
A Study to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 as Monotherapy and Combination Therapy in Subjects With BRAF V600 Mutant Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Adjuvant Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab for Resected High-Risk Melanoma in Participants With High-Risk Stage II-IV Melanoma (MK-7684A-010/KEYVIBE-010)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Investigate the Antitumor Activity, Safety, Tolerability, and Pharmacokinetics of BGB-A445 in Combination With Tislelizumab in Participants With Select Advanced Solid Tumors.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study Evaluating AB248 Alone or in Combination With Pembrolizumab in Adult Patients With Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Mentored Community Gardening for Individuals With Skin Cancer
- Status
- COMPLETED
- Phase
- NA
LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study
- Status
- RECRUITING
- Phase
- N/A
The Prognostic Value of 18F-PFPN PET Imaging in Patients With Malignant Melanoma
- Status
- UNKNOWN
- Phase
- N/A
A Study of Subcutaneous Nivolumab + Relatlimab Fixed-dose Combination (FDC) in Previously Untreated Metastatic or Unresectable Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Quantifying Systemic Immunosuppression to Personalize Cancer Therapy
- Status
- RECRUITING
- Phase
- N/A
MRI-Guided Focused Ultrasound Radiosensitization for Patients With Malignant Melanoma and Non Melanoma Skin Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Effects of Acute and Chronic Exercise on Myeloid-Derived Suppressor Cells in Melanoma Patients
- Status
- COMPLETED
- Phase
- NA
A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, or Dedifferentiated Liposarcoma
- Status
- RECRUITING
- Phase
- PHASE1